TITLE

Mycobacterium tuberculosis Interferes with the Response to Infection by Inducing the Host EphA2 Receptor

AUTHOR(S)
Khounlotham, Manirath; Subbian, Selvakumar; Smith III, Roger; Cirillo, Suat L. G.; Cirillo, Jeffrey D.
PUB. DATE
June 2009
SOURCE
Journal of Infectious Diseases;6/15/2009, Vol. 199 Issue 12, p1797
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Mycobacterium tuberculosis is an unusual pathogen, persisting for years in infected persons despite an immune response. Erythropoietin-producing hepatoma (Eph) receptors are critical for tissue organization. One hallmark of tuberculosis is the presence of granulomas consisting of organized immune cells. The importance of granuloma structure makes it likely that Eph receptors play a role in immunity to tuberculosis. Methods. We infected mice with low doses of M. tuberculosis by the aerosol method and examined the effects on ephA gene expression, pathology, composition of lymphocytes in the lungs (by flow cytometry), migration of CD4+ and CD8+ T cells, and numbers of cytokine-expressing cells. Results. Mice infected with M. tuberculosis displayed higher expression of ephA1 and ephA2 as well as ephrinA1, which encodes the ligand for EphA1 and EphA2. Interestingly, ephA2-/- mice displayed greater pathology, greater accumulation of T cells and dendritic cells, and higher levels of proinflammatory cytokines than did normal C57BL/6 mice. Furthermore, T cells from ephA2-/- mice migrated more efficiently than did those from C57BL/6 mice. Conclusions. These observations suggest that ephA-related genes may provide a mechanism that M. tuberculosis uses to circumvent the host response, given that accumulation of T cells appears to be due to the inhibition of immune cell migration by EphA2. Ultimately, the absence of ephA2 results in greater clearance of M. tuberculosis during the chronic phase of infection, suggesting that induction of ephA2 is important for the survival of M. tuberculosis during latency.
ACCESSION #
41534716

 

Related Articles

  • Attenuation of Toll-Like Receptor Expression and Function in Latent Tuberculosis by Coexistent Filarial Infection with Restoration Following Antifilarial Chemotherapy. Babu, Subash; Bhat, Sajid Q.; Kumar, N. Pavan; Anuradha, R.; Kumaran, Paul; Gopi, P. G.; Kolappan, C.; Kumaraswami, V.; Nutman, Thomas B. // PLoS Neglected Tropical Diseases;Jul2009, Vol. 3 Issue 7, p1 

    Mycobacterium tuberculosis (Mtb) and filarial coinfection is highly prevalent, and the presence of filarial infections may regulate the Toll-like receptor (TLR)-dependent immune response needed to control Mtb infection. By analyzing the baseline and mycobacterial antigen-stimulated expression of...

  • CLINICAL UTILITY OF THE TUBERCULOSIS INTERFERON GAMMA TEST (IGT) IN A LOW INCIDENCE AREA. Donovan, J. T.; Yogendran, A.; Ramsay, I. D.; Giles, C.; Lee, R. W.; Scourfield, A. T.; Doffman, S. R. // Thorax;Dec2011 Supplement, pA74 

    Introduction The clinical utility and cost effectiveness of IGT in low prevalence areas of TB remains unclear. In some clinical settings it has been used to exclude active disease. We describe the experience of IGT in a teaching hospital in a low prevalence area (13/100 000). Methods We...

  • Comparative Proteomics of Activated THP-1 Cells Infected with Mycobacterium tuberculosis Identifies Putative Clearance Biomarkers for Tuberculosis Treatment. Kaewseekhao, Benjawan; Naranbhai, Vivek; Roytrakul, Sittiruk; Namwat, Wises; Paemanee, Atchara; Lulitanond, Viraphong; Chaiprasert, Angkana; Faksri, Kiatichai // PLoS ONE;7/27/2015, Vol. 10 Issue 7, p1 

    Biomarkers for determining clearance of Mycobacterium tuberculosis (Mtb) infection during anti-tuberculosis therapy or following exposure could facilitate enhanced monitoring and treatment. We screened for biomarkers indicating clearance of Mtb infection in vitro. A comparative proteomic...

  • Mechanisms of control of Mycobacterium tuberculosis by NK cells: role of glutathione. Allen, Michael; Bailey, Cedric; Cahatol, Ian; Dodge, Levi; Yim, Jay; Kassissa, Christine; Luong, Jennifer; Kasko, Sarah; Pandya, Shalin; Venketaraman, Vishwanath // Frontiers in Immunology;Oct2015, Vol. 6, p1 

    Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tb), continues to be one of the most prevalent infectious diseases in the world. There is an upward trend in occurrence due to emerging multidrug resistant strains and an increasingly larger proportion of immunocompromised patient...

  • Th17: A New Player to be Considered in Tuberculosis Studies. Pedroza-Roldán, Cesar; Barba, Jeannette; Flores-Valdez, Mario Alberto // Journal of Bacteriology & Parasitology;2012, Vol. 3 Issue 9, p1 

    The article presents author's views on the aspects of Mycobacterium tuberculosis (TB). He mentions a report submitted by World Health Organization (WHO) which shows that Mycobacterium tuberculosis is responsible for major deaths around the world. He also discusses the functions of dendritic...

  • Novel T-Cell Assays for the Discrimination of Active and Latent Tuberculosis Infection: The Diagnostic Value of PPE Family. Pourakbari, Babak; Mamishi, Setareh; Marjani, Majid; Rasulinejad, Mehrnaz; Mariotti, Sabrina; Mahmoudi, Shima // Molecular Diagnosis & Therapy;Oct2015, Vol. 19 Issue 5, p309 

    Objective: The diagnosis of active and latent tuberculosis remains a challenge. Although a new approach based on detecting Mycobacterium tuberculosis-specific T-cells has been introduced, it cannot distinguish between latent infection and active disease. The aim of this study was to evaluate the...

  • Towards host-directed therapies for tuberculosis. Zumla, Alimuddin; Chakaya, Jeremiah; Hoelscher, Michael; Ntoumi, Francine; Rustomjee, Roxana; Vilaplana, Cristina; Yeboah-Manu, Dorothy; Rasolof, Voahangy; Munderi, Paula; Singh, Nalini; Aklillu, Eleni; Padayatchi, Nesri; Macete, Eusebio; Kapata, Nathan; Mulenga, Modest; Kibiki, Gibson; Mfinanga, Sayoki; Nyirenda, Thomas; Maboko, Leonard; Garcia-Basteiro, Alberto // Nature Reviews Drug Discovery;Aug2015, Vol. 14 Issue 8, p511 

    The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.

  • Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis. Idh, Jonna; Mekonnen, Mekidim; Abate, Ebba; Wedajo, Wassihun; Werngren, Jim; Ängeby, Kristian; Lerm, Maria; Elias, Daniel; Sundqvist, Tommy; Aseffa, Abraham; Stendahl, Olle; Schön, Thomas // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Background and Objective: The relative contribution of nitric oxide (NO) to the killing of Mycobacterium tuberculosis in human tuberculosis (TB) is controversial, although this has been firmly established in rodents. Studies have demonstrated that clinical strains of M. tuberculosis differ in...

  • Caspofungin/rifampicin interaction.  // Reactions Weekly;10/6/2012, Issue 1422, p15 

    The article describes the case of a 65-year-old woman who developed Candida (C.) parapsilosis candidaemia due to failure of treatment with caspofungin for C. lusitaniae while receiving rifampicin for Mycobacterium tuberculosis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics